Reentry Assist (R-Assist)
R-Assist
Reentry-Assist App Development for Individuals With Addiction and Mental Illness
2 other identifiers
interventional
38
0 countries
N/A
Brief Summary
This project will aim to develop and pilot test, R-Assist, a mobile health application to support individuals with co-occurring substance use and mental health disorders (COD) in their recovery, who have recently released from a participating Massachusetts jail.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2025
CompletedFirst Posted
Study publicly available on registry
May 20, 2025
CompletedStudy Start
First participant enrolled
June 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 29, 2025
CompletedMay 25, 2025
May 1, 2025
3 months
May 12, 2025
May 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
App usage
Total time engaged in app will be tracked daily during open pilot period. Additionally, engagement and time with each feature will be tracked
From enrollment for 1.5 months during the open pilot
System Usability Scale (SUS)
Overall score will be computed, indicating overall usability Score ranges from 0-100 (0-64=not acceptable, 65-84=acceptable, and 85, 100=excellent.
From enrollment for 1.5 months during the open pilot
Mobile Application Rating Scale (MARS)
Overall score will be computed, indicating overall acceptability, as well as score for each of the four dimensions. The rating scale assesses app quality on four dimensions (1. Engagement, 2. Functionality, 3. Aesthetics, and 4. Information). All items are rated on 5-point scale from "1=inadequate" to "5=excellent"
From enrollment for 1.5 months during the open pilot
Composite International Diagnostic Instrument for DSM-IV: Social determinants of health (SDOH) linkages
SDOH needs (e.g., housing instability, food insecurity, NA/AA/ other recovery linkages) will be assessed and the App will track all referrals and SDOH linkages made. Percent of linkages made to needed SDOH services will be examined.
From enrollment for 1.5 months during the open pilot
Composite International Diagnostic Instrument for DSM-IV: Substance Use Disorder
Substance use disorder symptoms will be tracked daily during the open pilot period.
From enrollment for 1.5 months during the open pilot
Composite International Diagnostic Instrument for DSM-IV: Mental Health
Mental health symptoms will be tracked daily during the open pilot period.
From enrollment for 1.5 months during the open pilot
Study Arms (1)
R-Assist
EXPERIMENTALParticipants who have recently released from jail will engage with the R-assist app for up to 1.5 months
Interventions
R-Assist features will include: 1) daily self-reported symptom and medication management monitoring; 2) a 29-session MISSION-CJ self-help curriculum, with an accompanying library of recovery resources to support COD symptom management and promote prosocial thinking and behavior; 3) SDOH resource finder; and 4) a dashboard to track R-Assist engagement.
Eligibility Criteria
You may qualify if:
- Have been released from the participating jail within the past 150 days
- Own a smartphone (Android or iOS; 90% met this criterion in our prior studies)
- Have COD: any substance use disorder (we will allow poly-substance use disorders) and a co-occurring mental health disorder (depression, anxiety, trauma related disorders, bipolar, and/or schizophrenia)
- Consent to R-Assist app use observation and e-tracking
- Consent to audio recording during interviews and focus groups.
You may not qualify if:
- Acutely suicidal, homicidal, or psychotic
- Unable to provide informed consent
- Individuals released with monitoring devices or individuals involved in drug treatment courts
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Meaningful Measurement, Inclead
- National Institute on Drug Abuse (NIDA)collaborator
- University of Massachusetts, Worcestercollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Smelson, PsyD
University of Massachusetts Chan Medical School
- PRINCIPAL INVESTIGATOR
Donna Surges Tatum, PhD
Meaningful Measurement, LLC
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2025
First Posted
May 20, 2025
Study Start
June 1, 2025
Primary Completion
August 31, 2025
Study Completion
September 29, 2025
Last Updated
May 25, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share